DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) inhibits chemotherapeutic drug-induced autophagy
Our previous work found that DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo [1,5-a]pyrimidin-3-yl]quinoline) was a novel autophagy inhibitor. Here, we aimed to investigate the effects of DMH1 on chemotherapeutic drug-induced autophagy as well as the efficacy of chemotherapeutic drugs in different cancer ce...
Main Authors: | Yue Sheng, Bo Sun, Xin Xie, Na Li, Deli Dong |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-07-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383515000027 |
Similar Items
-
The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-<i>e</i>]tetrazolo[4,5-<i>b</i>][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells
by: Agnieszka Gornowicz, et al.
Published: (2020-07-01) -
Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-<i>d</i>]pyrimidine Tyrosine Kinase Inhibitors
by: Sofija Jovanović Stojanov, et al.
Published: (2022-09-01) -
Autophagy in 5-Fluorouracil Therapy in Gastrointestinal Cancer: Trends and Challenges
by: Jia-Cheng Tang, et al.
Published: (2016-01-01) -
4-Benzylsulfanyl-1H-pyrazolo[3,4-d]pyrimidine
by: Mohammed El Fal, et al.
Published: (2013-11-01) -
Autophagy and Breast Cancer: Connected in Growth, Progression, and Therapy
by: Qitong Wu, et al.
Published: (2023-04-01)